Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

Circulation

Volumn 106, Issue 2, 2002, Pages 246-253

  Candido, Riccardo ^a   Jandeleit Dahm, Karin A ^a   Cao, Zemin ^a   Nesteroff, Stefan P ^a   Burns, Wendy C ^a   Twigg, Stephen M ^a   Dilley, Rodney J ^a   Cooper, Mark E ^a   Allen, Terri J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angiotensin; Atherosclerosis; Diabetes mellitus; Vessels

Indexed keywords

ALPHA ACTIN; APOLIPOPROTEIN E; CONNECTIVE TISSUE GROWTH FACTOR; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME INHIBITION; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES;

ACTINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; GROWTH SUBSTANCES; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; PHAGOCYTES; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037047082     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000021122.63813.32     Document Type: Article

References (35)

1. Morbidity and mortality in diabetics in the Framingham population: Sixteen year follow-up study
2. Five-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
4. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice
5. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
6. Pathogenesis, prevention, and treatment of diabetic nephropathy
7. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
8. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
9. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
10. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions
11. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion
12. Fispl2/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo
13. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells
14. Inflammation and atherosclerosis
15. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice
16. A noninvasive computerized tail-cuff system for measuring blood pressure in mice
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
18. Vascular expression of angiotensin type 2 receptor in the adult rat: Influence of angiotensin II infusion
19. Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products
20. 125I-labelled MK351A
21. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily
22. Dyslipidemia and diabetes: Animal models
23. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol
24. Evidence that macrophages in atherosclerotic lesions contain angiotensin II
25. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters: Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids
26. Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin
27. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice
28. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
29. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
30. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover
31. Angiotensin II induces vascular cell adhesion moleculeexpression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
32. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage
33. Cyclosporine induces myocardial connective tissue growth factor in spontaneously hypertensive rats on high-sodium diet
34. The low density lipoprotein receptor-related protein/alpha 2- macroglobulin receptor is a receptor for connective tissue growth factor
35. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions